DE3680796D1 - Chinolincarbonsaeuretabletten und formulierungen. - Google Patents

Chinolincarbonsaeuretabletten und formulierungen.

Info

Publication number
DE3680796D1
DE3680796D1 DE8686100487T DE3680796T DE3680796D1 DE 3680796 D1 DE3680796 D1 DE 3680796D1 DE 8686100487 T DE8686100487 T DE 8686100487T DE 3680796 T DE3680796 T DE 3680796T DE 3680796 D1 DE3680796 D1 DE 3680796D1
Authority
DE
Germany
Prior art keywords
formulations
carbonic acid
acid tablets
chinoline
chinoline carbonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686100487T
Other languages
English (en)
Inventor
Ashok V Katdare
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE3680796D1 publication Critical patent/DE3680796D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8686100487T 1985-01-22 1986-01-16 Chinolincarbonsaeuretabletten und formulierungen. Expired - Lifetime DE3680796D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/693,071 US4639458A (en) 1985-01-22 1985-01-22 Tablet and formulation

Publications (1)

Publication Number Publication Date
DE3680796D1 true DE3680796D1 (de) 1991-09-19

Family

ID=24783194

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686100487T Expired - Lifetime DE3680796D1 (de) 1985-01-22 1986-01-16 Chinolincarbonsaeuretabletten und formulierungen.

Country Status (9)

Country Link
US (1) US4639458A (de)
EP (1) EP0189114B1 (de)
JP (1) JPH0784386B2 (de)
CA (1) CA1273877A (de)
DE (1) DE3680796D1 (de)
DK (1) DK28786A (de)
ES (1) ES8705758A1 (de)
LV (1) LV5722B4 (de)
PT (1) PT81836B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4850993A (en) * 1986-12-22 1989-07-25 Miles Laboratories, Inc. Blood bag system incorporating quinolone carboxylic, acid derivatives
JP2804048B2 (ja) * 1987-09-11 1998-09-24 イー・アール・スクイブ・アンド・サンズ・インコーポレイテッド 高薬物含量医薬組成物およびその製造法
NZ226696A (en) * 1987-11-02 1991-10-25 Merck & Co Inc Tablet composition comprising a phthalazine acetic acid derivative as the active ingredient present in from 83-88 wt%
FR2638971B1 (fr) * 1988-11-15 1993-01-08 Vacher Dominique Comprime a delitement et/ou dissolution instantane
ATE108649T1 (de) * 1990-02-14 1994-08-15 Takeda Chemical Industries Ltd Brausemischung, deren herstellung sowie verwendung.
US5225201A (en) * 1991-08-23 1993-07-06 Minnesota Mining And Manufacturing Company Salsalate tablet
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
FR2711524B1 (fr) * 1993-10-21 1995-11-24 Rhone Dpc Europ Procédé de préparation de compositions orales contenant des quinolones.
US20010007863A1 (en) 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
ATE199495T1 (de) * 1994-12-14 2001-03-15 Enbalt Trading Ltd Pharmazeutische zubereitung zur direktverpressung
KR100405116B1 (ko) * 1995-02-28 2004-02-05 아벤티스 파마슈티칼스 인크. 피페리디노알칸올화합물에대한약제학적조성물
US6488961B1 (en) 1996-09-20 2002-12-03 Ethypharm, Inc. Effervescent granules and methods for their preparation
US6649186B1 (en) 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
CZ295461B6 (cs) * 1997-08-26 2005-08-17 Aventis Pharmaceuticals Inc. Farmaceutický prostředek ve formě dvouvrstvé tablety
IN186245B (de) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
AU2003225837B2 (en) * 2002-03-15 2008-11-06 Forest Laboratories Holdings Limited NE and 5-HT reuptake inhibitors for treating visceral pain syndromes
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
ATE382338T1 (de) * 2003-03-19 2008-01-15 Jordanian Pharmaceutical Mfg Nicht-hygroskopische pharmazeutische zusammensetzungen die nicht hydratisierte quinolon-carbonsäure enthalten
MX350659B (es) * 2011-11-30 2017-09-13 Toyama Chemical Co Ltd Tableta que contiene hidrato de metansulfonato del acido 1-ciclopropil- 8 - (difluorometoxi) -7- [ (1r) -1-metil-2,3-dihidro-1h-isoindol-5-il] -4-oxo-1,4-dihidroquinolin- 3-carboxilico.
CN107115312A (zh) * 2017-05-17 2017-09-01 湖南新汇制药股份有限公司 一种诺氟沙星片及其制备方法
CN107669645A (zh) * 2017-10-31 2018-02-09 瑞阳制药有限公司 盐酸环丙沙星片的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US29077A (en) * 1860-07-10 Cabpet-sweepee
US4072535A (en) * 1970-12-28 1978-02-07 A. E. Staley Manufacturing Company Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules
USRE29077E (en) 1972-12-06 1976-12-14 Ives Laboratories Inc. Tablet formulation
US3873694A (en) * 1973-09-27 1975-03-25 Cpc International Inc Direct compression tabletting composition and pharmaceutical tablets produced therefrom
US4097606A (en) * 1975-10-08 1978-06-27 Bristol-Myers Company APAP Tablet containing an alkali metal carboxymethylated starch and processes for manufacturing same
DE3013839A1 (de) * 1979-04-13 1980-10-30 Freunt Ind Co Ltd Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
US4293539A (en) * 1979-09-12 1981-10-06 Eli Lilly And Company Controlled release formulations and method of treatment
JPS57134482A (en) * 1981-02-13 1982-08-19 Dainippon Pharmaceut Co Ltd 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4530928A (en) * 1982-01-13 1985-07-23 Merck & Co., Inc. Quinoline carboxylic acid complexes with guanidinium carbonate
US4440740A (en) * 1982-04-26 1984-04-03 Merck & Co., Inc. α-Keto aldehydes as enhancing agents of gastro-intestinal drug absorption
US4522818A (en) * 1982-10-14 1985-06-11 Pennwalt Corporation Diuretic/antihypertensive compositions
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
US4478822A (en) * 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels

Also Published As

Publication number Publication date
DK28786D0 (da) 1986-01-21
EP0189114A3 (en) 1987-08-26
LV5722B4 (lv) 1996-06-20
PT81836A (en) 1986-02-01
DK28786A (da) 1986-07-23
EP0189114B1 (de) 1991-08-14
JPS61167618A (ja) 1986-07-29
JPH0784386B2 (ja) 1995-09-13
ES8705758A1 (es) 1987-05-16
US4639458A (en) 1987-01-27
CA1273877A (en) 1990-09-11
PT81836B (pt) 1987-11-30
LV5722A4 (lv) 1996-02-20
EP0189114A2 (de) 1986-07-30
ES551081A0 (es) 1987-05-16

Similar Documents

Publication Publication Date Title
DE3680796D1 (de) Chinolincarbonsaeuretabletten und formulierungen.
KR880701541A (ko) 마이크로 캡슐을 포함하는 제약학적 배합물
DK330287A (da) Antiinflammatorisk forbindelse og farmaceutisk sammensaetning indeholdende samme
DK546886D0 (da) Farmaceutisk praeparat
DK539786A (da) Tiazolo(4,5-c)quinoliner og laegemiddelpraeparater indeholdende saadanne forbindelser
DE3676248D1 (de) Ubidecarenon enthaltende arzneimittel.
KR870700608A (ko) 아미노-살리실산 유도체 및 제약 조성물
DK518687D0 (da) Imidazo-benzoxazinoner, deres fremstilling og laegemidler indholdende forbindelserne
DK259186A (da) Nasale farmaceutiske praeparater
DE3576335D1 (de) Chinolincarbonsaeure-derivate.
DK287188A (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
DE3671446D1 (de) 5-aralkylsubstituierte 2h-benztriazole und stabilisierte zusammensetzungen.
DK456686D0 (da) Stabiliseret human prourokinase
MX5577A (es) Formulacion farmaceutica
DK52086D0 (da) Farmaceutiske praeparater indeholdende ergotalkaloider
DE3674017D1 (de) Oxalursaeure-derivate und pharmazeutisches mittel.
DE3650451T2 (de) Geisteskrankheittherapeutisches Mittel
FR2580497B1 (fr) Compositions pharmaceutiques en comprimes
DE3869906D1 (de) Chinolincarbonsaeure-derivate.
DE3669656D1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.
IT1200467B (it) Formulazione farmaceutica
IT8647615A0 (it) Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli
DK151785A (da) 3-aminoalkylthio-1-phenylindolforbindelser og farmaceutiske praeparater
DE3670083D1 (de) Pharmazeutische pyrrolizidinverbindungen und -zusammensetzungen und ihre herstellung.
KR860005809A (ko) 3--1h-인다졸, 이의 제조방법 및 이들 화합물을 함유하는 약제학적 조성물

Legal Events

Date Code Title Description
8364 No opposition during term of opposition